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SI Materials and Methods
Below we present our Combinatorial Alternate Exon quantitative
PCR (CAE-qPCR) method and its validation and provide full
experimental procedures for analysis of wild-type and mutant
Caenorhabditis elegans strains.
CAE-qPCR Method. We used a probe hydrolysis-based (Taqman)
strategy to quantify the expression of the 12 slo-1 splice variants
because it relies on speciﬁc hybridization of oligonucleotides at
three sites along the target cDNA. Our method uses primer pairs
that speciﬁcally hybridize to the 5′ alternate exon (A1 or A2) and
the 3′ alternate exon (C0 or C1) of the target cDNA and probes
that hybridize to a speciﬁc alternate exon at site B (B0, B1, or
B2) (Fig. 2A). Each probe has a ﬂuorophore and a quencher
covalently bound to the 5′ end and the 3′ end, respectively. At
each PCR cycle, the endonuclease 5′–3′ activity of Taq poly-
merase cleaves the probe, releasing the ﬂuorophore from the
quencher and allowing real-time monitoring of target ampliﬁ-
cation. Using the set of primers and probes with high binding
speciﬁcities, each of the 12 A-B-C primer and probe combina-
tions should detect only one single transcript. Below we describe
our strategy for optimizing primer and probe sets to speciﬁcally
amplify target transcripts with minimal cross-reactivity to other
splice variants. This validation process leveraged the set of
plasmids carrying full-length slo-1 splice variants used in our
biophysical characterization of the properties of alternative BK
channel isoforms (1).
Primer validation. We designed primers (Fig. S1A and Table S1)
that speciﬁcally hybridize to each alternate exon with minimal
cross-reactivity. To quantify the expression of transcripts lacking
inserts at sites B and C, we designed primers that span the splice
junction between the ﬂanking constitutive exons. To validate that
the selected primers could efﬁciently amplify the target tran-
scripts when present in a complex template mixture, we evalu-
ated their ability to amplify slo-1 transcripts in a C. elegans cDNA
library generated by reverse transcription (RT) of total RNA
with random hexamers. PCR reactions were performed with
each of the four A/C primer pairs, followed by electrophoresis
analysis. The four reactions produced bands of expected size
(500–550 bp) (Fig. S1B). The products were cleaved by BsmI
restriction enzyme digestion, and the fragments were of the
predicted sizes (Fig. S1B), conﬁrming the speciﬁc ampliﬁcation
of slo-1. Slight differences in size allowed a gross evaluation of B
site splicing events using PCR products obtained from cDNA
plasmid templates as a size standard.
Next, we used a dye-based real-time qPCR approach to further
optimize cycling parameters and to quantitatively evaluate the
cross-reactivity of each A-C primer pair with the nontargeted
splice variants. Each primer pair was tested against four cDNA
plasmid templates (in each case, one match and three mismatch
templates). Representative ampliﬁcation proﬁles are shown in
Fig. S1C. For A1/C0, A1/C1, and A2/C1 primer pairs, a shift of at
least 10 cycles was observed between match and mismatch tem-
plates. This indicates that the signal generated for targeted splice
variants is at least three orders of magnitudes (210) higher than
the one generated with nonspeciﬁc templates, assuming ideal
ampliﬁcation efﬁciency. The A2/C0 primer pair did amplify
a nonspeciﬁc A1;C0-type splice variant with ≈100-fold (27) lower
efﬁciency than the target splice variant. Cross-reactivity will
therefore be negligible in samples in which all variants are
present in similar abundance. However, for transcripts expressed
at relatively low levels, a signiﬁcant fraction of the signal may be
due to cross-reactivity with nonspeciﬁc templates present at
much higher concentration. To quantitatively evaluate this ef-
fect, we calculated a cross-reactivity factor for each mismatched
combination of templates and primer pairs (Tables S2 and S3).
These factors were used to control a posteriori for cross-re-
activity in the data obtained with RT-derived cDNA templates.
Probe validation. We designed hydrolysis probes to speciﬁcally
recognize each of the three possible splicing events at site B: B0,
B1, or B2. Although the probe targeted to B2 complements a
unique sequence that is missing from B1 and B0 variants, probes
targeted to B0 and B1 hybridize to exon boundaries where
portions of the hybridizing sequence is shared by multiple splice
variants, presenting a risk for cross-reactivity. We evaluated this
risk by performing real-time PCR analysis with plasmid cDNA
templates. Each probe was tested against three cDNA templates
(in each case, one match and two mismatch templates; Fig. S1D).
The match templates all gave stronger signals, which were de-
tectable at lower cycles than the mismatch templates. Cross-
reactivity factors were calculated for each probe on the basis of
the cycle differences (Tables S2 and S3). Because this factor is
strongly dependent upon the set signal threshold for quantitative
cycle determination, we held the signal threshold constant for all
CAE-qPCR measurements.
qPCR efﬁciency. The ampliﬁed portion of each slo-1 splice variant is
longer than the 150- to 200-base pair amplicons typically rec-
ommended for efﬁcient probe-hydrolysis qPCR. We sought to
control for this empirical limitation by measuring the efﬁciency
and accuracy of the probe-hydrolysis qPCR for detecting each of
the 12 splice variants. To do this, we used probe-hydrolysis qPCR
to amplify plasmid cDNAs and to generate standard curves cov-
ering three orders of magnitude in copy number variation (10–
10,000). The cycle where the ﬂuorescence signal crossed the
threshold (Ct) was plotted as a function of the logarithm of the
initial template concentration. The best linear ﬁt was calculated
by linear regression. Table S4 reports the thresholds, slopes, in-
tercepts, regression coefﬁcients (R2), and the calculated PCR
efﬁciencies. R2 values were above 0.99, and the calculated efﬁ-
ciency average was 97% (SD 6%), indicating that the large am-
plicon size limited neither signal detection nor ampliﬁcation.
Controlling for cross-hybridization effects in worm lysate-derived cDNA
samples. With the CAE-qPCR method in place, we quantiﬁed
the absolute abundance of each of the 12 slo-1 splice variants
from worm lysate-derived cDNA samples. To begin, we prepared
total RNA samples from ﬁve independent populations of young
adult wild-type (N2) animals. Next, samples were reverse tran-
scribed with a slo-1–speciﬁc primer that hybridized to the bound-
ary between the constitutive exons 17 and 18, downstream of the
alternatively spliced region of the gene. Finally, we used CAE-
qPCR to measure splice variant expression. We converted Ct
values to copy number using the standard curves generated from
plasmid cDNA templates, yielding an absolute quantiﬁcation of
splice variant copy number. Between 10 and 4,300 copies were
detected per CAE-qPCR reaction. It was therefore important to
carefully evaluate cross-hybridization of primers and probes to
avoid overestimating the amount of the least abundant tran-
scripts. Cross-reactivity factors previously determined for each
probe and primer combination (Tables S2 and S3) were used to
calculate the fraction of the measured copy number that was
caused by ampliﬁcation and detection of nonspeciﬁc templates.
For 10 of the 12 splice variants, the maximum error due to cross-
reactivity was signiﬁcantly smaller than the SD of the measured
values across ﬁve replicates. The remaining two splice variants
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A1;B0;C0 and A1;B0;C1 produced very low ampliﬁcation sig-
nals, and the calculated cross-reactivity errors were similar to the
measured signal. Thus, these two transcripts were expressed
below the detection threshold and were omitted from further
analyses.
Controlling for PCR reagent titration in multitemplate samples. PCR
reagent-titration effects bias the results of quantitative PCR
analysis when the DNA template contains a mix of splice variants
present at very different concentrations (2). These effects occur
among splice-variant amplicons that have identical primer-
hybrization sequences but contain distinct probe-binding sites.
For slo-1 splice variants analyzed by CAE-qPCR, three templates
are ampliﬁed in parallel by each A/C primer pair (one containing
B0, one containing B1, and one containing B2) regardless of the
probe used to monitor the reaction. Thus, competition effects
may produce a titration of PCR reagents during the ampliﬁca-
tion of nontargeted splice variants. The ampliﬁcation of the least
abundant transcript produces a weaker signal, likely owing to
the depletion of primers and/or the saturation of the polymerase
by the parallel ampliﬁcation of more abundant, nontargeted
splice variants.
To determine whether signiﬁcant underestimations arose from
such competition effects, we empirically measured the concen-
tration ratio at which a competing nontargeted splice variant
affects ampliﬁcation efﬁciency for the targeted splice variant.
Among A2;C0-type splice variants there is a ≈20-fold difference
in expression levels, so we evaluated how the presence of the
abundantly expressed A2;B0;C0 splice variant affected the de-
tection of the less-abundant transcript A2;B1;C0. Fig. S2A com-
pares ampliﬁcation proﬁles obtained from pure plasmid cDNA
and mixed-template RT-derived cDNA samples for both A2;B0;
C0 and A2;B1;C0. qPCR ampliﬁcation curves for reactions
containing a single template of either A2;B0;C0 or A2;B1;C0
show strong signals with a large range of exponential ampliﬁca-
tion (linear portion of the curve in the semilog plot, Fig. S2A).
The ampliﬁcation proﬁle for A2;B0;C0 from RT-derived tem-
plate cDNA is similar to that of pure plasmid cDNA, indicating
that this abundant transcript is, as expected, not subject to
a competition effect. In the case of A2;B1;C0, ampliﬁcation
traces obtained from RT-derived cDNA samples reached lower
signal amplitude than the signal obtained with pure plasmid
templates. These observations suggest that the shift is likely due
to a competition effect.
Generally, the signal intensity threshold for measuring Ct is set
in the middle of the exponential range of the ﬂuorescence curve,
where the signal to noise ratio is high. For splice variants ex-
pressed at low levels, the exponential range of the ﬂuorescent
signal was often very narrow. We minimized the effects of PCR
reagent titration by ﬁnding the minimum usable signal threshold
that would not compromise the signal to noise ratio or the
measured ampliﬁcation efﬁciency. To establish this optimal sig-
nal threshold, pure cDNA templates of A2;B0;C0 and A2;B1;C0
of known concentration were mixed to recreate the conditions
from the worm cDNA template pool. First, the A2;B1;C0 target
cDNA was held constant while the amount of A2;B0;C0 com-
petitor cDNA was progressively increased. Increasing the com-
petitor cDNA decreased the amplitude of signal but not the
Ct value when the threshold was set below 0.01 (Fig. S2B).
To evaluate the concentration difference between target and
competing splice variants at which the PCR reagent titration
effect would bias the analysis, we compared standard curves for
the A2;B1;C0 target generated in the presence or absence of the
A2;B0;C0 competitor. We used the same concentration of A2;B0;
C0 as was measured from the mixed worm cDNA pool generated
by RT. The ﬂuorescence proﬁle of the A2;B1;C0 splice variant in
the presence of competitor deviates from the control reaction
(with no competitor) when the competing A2;B0;C0 splice variant
concentration is 25-fold more abundant than the target splice
variant (Fig. S2C). This result suggests that the PCR reagent
titration effect did not cause a signiﬁcant bias in the quantiﬁ-
cation of A2;B1;C0, because the maximum difference in RT-
derived cDNA samples was 20-fold. To further conﬁrm this
conclusion, we created a plasmid cDNA mix that recapitulated
the measured values and compared these results with those ob-
tained from the worm cDNA pool. The ampliﬁcation proﬁles
were very similar, recapitulating the decreased signal amplitude
at high cycles and yielding the same Ct at the established signal
threshold (Fig. S2D). Thus, PCR reagent titration effects can be
minimized by empirically determining the signal threshold value
at which the results from both pure cDNA and mixed RT-
derived cDNA templates are congruent.
Collectively, the results of our detailed analysis of cross-
reactivity and titration effects indicate that the CAE-qPCR
method developed here produced an accurate and absolute
quantiﬁcation of slo-1 splice variants.
Primer Design and Synthesis. Exon-speciﬁc primers were used in
the CAE-qPCR technique and for dye-based qPCR. Although the
A1 and A2 alternate exons are similar in sequence, we designed
primers that hybridize with unique regions in each alternate exon.
C1 primer design was straightforward because it recognizes a
sequence that is only present in C1-type variants. The C0 splicing
event is the exclusion of exon 15 and the introduction of a junction
between exon 14 and 16 that is absent fromC1-type variants. Four
candidate primers overlapping this exon boundary were tested by
standard PCR with plasmid templates carrying cDNA clones for
C0 and C1 variants. One of the primers, showing no detectable
cross-reactivity with C1 containing templates, was selected. Ad-
ditional primers were used to quantify the abundance of all slo-1
transcripts (forward primer at the boundary of exons 16 and 17,
reverse primer on exon 18), as well as the abundance of refer-
ence genes by dye-based qPCR. All primers were synthesized at
the Protein and Nucleic Acid Facility at Stanford University.
Sequences are reported in Table S1.
Probe Design and Synthesis. We designed hydrolysis probes
(Taqman probes) to recognize each of the three possible splicing
events at site B: B0, B1, or B2. For the B2-speciﬁc probe, we
targeted the unique sequence at the 5′ end of exon 13 that is
missing from B1 and B0 variants. For the B1-speciﬁc probe, we
targeted the boundary between exon 12 and the B1 form of exon
13. This is the only region that differs from B2 variants. For the
B0 speciﬁc probe, we targeted the boundary between exon 12
and 14. Two candidate B0 probes were tested; we selected the
one with the least cross-reactivity with B1 and B2. All probes
were covalently bonded to Fam ﬂuorophore in 5′ and a black
hole quencher (BHQ) in 3′ and were synthesized at Biosearch
Technologies. Probe sequences are reported in Table S1.
Quantitative PCR. Dye-based qPCR experiments were performed
with PowerSYBR Master Mix (Applied Biosystems) in a ﬁnal
volume of 20 μL. We evaluated total cDNA abundance from RT-
derived samples for wild-type (N2) and slo-1(pg52) animals by
quantifying the expression of two reference genes, cdc-42 and
pmp-3, whose expression was previously shown to be very stable
(3). For the CAE-qPCR approach, probe hydrolysis (Taqman)
analyses were performed with Taqman Gene Expression Master
Mix (Applied Biosystems) in a ﬁnal volume of 30 μL. Primer and
probe ﬁnal concentrations were 1 μM and 500 nM, respectively.
All real-time PCR experiments were performed in a StepOne-
Plus apparatus (Applied Biosystems) at the Protein and Nucleic
Acid Facility at Stanford University. The default thermal cycling
proﬁle was used, except for the elongation time, which was ex-
tended to 30 s, and the annealing temperature, which was in-
creased to 63 °C. These parameters minimized cross-reactivity
between splice variants, without impairing PCR efﬁciency.

ht
tp
://
do
c.
re
ro
.c
h
Standard curves for absolute quantiﬁcation were made with
serial dilutions of plasmids carrying each of the 12 slo-1 splice
variants and were included in each PCR run. Control reactions
lacking reverse transcriptase (“No reverse transcriptase”) and
cDNA templates (“No cDNA template”) were analyzed in par-
allel. For dye-based qPCR experiments, dissociation curves were
performed to verify that a unique product was ampliﬁed for both
plasmid cDNA and RT-derived sample cDNA templates. For
RT-derived samples, cDNA templates generated from 40 ng of
starting total RNA were analyzed in each reaction. Results are
reported as cDNA copy numbers in a sample of this size.
Sequencing. To identify the pg52 point mutation, genomic DNA
was ampliﬁed using standard PCR conditions (see primer se-
quences in Table S1) and sequenced (Sequetech).
C. elegans StrainMaintenance, Total RNA Extraction, and RT.C. elegans
nematodes were maintained and age-synchronized according to
standard procedures (4). We used homogenous, synchronized
populations of young adult animals for behavioral analysis, RNA
extraction, and RT. Total RNA was extracted with TRIzol re-
agent (Invitrogen), and ﬁve independent replicates were analyzed
for each genotype. RNA (12 μg) from each sample was reverse
transcribed with the SuperScript Vilo cDNA Synthesis Kit (In-
vitrogen) in a ﬁnal volume of 100 μL according to supplier in-
structions, except that 10 μM of the slo-1 variable region-speciﬁc
reverse primer CCACGTGTTTGAGCTCATGAT was included
in the reaction mix in addition to random hexamers. All samples
and controls were puriﬁed and concentrated (Zymo Research)
to a ﬁnal volume of 100 μL.
C. elegans Chemical Mutagenesis, Genetic Screen, and Behavioral
Studies. Synchronized (L4-stage) unc-2(ra612) animals were mu-
tagenized by exposure to ethyl methanesulfone (EMS) according
to standard procedures (5). Brieﬂy, animals were washed off
growth plates, pelleted, resuspended in M9 saline (4 mL) con-
taining EMS (225 μM), and incubated with gentle agitation for
4 h. Next, animals were washed twice in fresh M9 and transferred
to growth plates seeded with OP50 Escherichia coli for 1–2 h.
Twenty healthy, young adult P0 animals were transferred to in-
dividual plates and incubated at 20 °C for 24 h. P0s were removed
from the plates, and F1s were incubated for another 48 h. Five
hundred F1 animals were transferred to individual growth plates;
their F2 progeny were assayed for sensitivity to aldicarb when
most animals in each population were at the young adult stage.
Aldicarb hypersensitive individuals were selected and used to
establish lines of putative mutants, which were tested in sub-
sequent generations to identify true-breeding mutants and
eliminate false positives. We assayed sensitivity to aldicarb as
follows. First, F2 populations were transferred to small (35 mM)
nematode growth medium (NGM) agar assay plates containing
aldicarb (1 mM; Chem Service) for 3 h. Next, the degree of
paralysis observed in F2 animals was compared with control unc-
2(ra612) animals, which are resistant to aldicarb-induced paral-
ysis. Finally, we selected individual paralyzed animals (putative
mutants) and transferred them to individual growth plates. Al-
dicarb hypersensitivity was conﬁrmed in the F3 and F4 gen-
erations. For both genetic screening and behavioral studies,
aldicarb assay plates were prepared by pouring 3 mL molten
NGM agar containing aldicarb (1 mM) into small Petri plates (35
mm). Plates were used within 2 d.
We measured aldicarb sensitivity of wild-type and mutant
animals as follows. Between 20 and 25 animals were placed onto
aldicarb plates, and the number of paralyzed worms was counted
every 30 min for the duration of the assay. We deﬁned a paralyzed
animal as one that is unable tomove any part of its body during a 2-
to 3-s observation period. Animals were not stimulated to de-
termine paralysis. Data presented in Fig. 3B were obtained with
Worm Tracker (6), providing a semiautomated quantiﬁcation of
the paralysis kinetics.
Probability-Based Modeling. Nonconditional probabilities were
calculated from the frequency of each splice variant in the total
pool of slo-1 transcripts. Conditional probabilities were calcu-
lated from the frequency of each variant in subgroups as follows:
P(AijBj) = P(all Ai;Bj containing variants)/P(all Bj containing
variants)
P(BjjAi) = P(all Ai;Bj containing variants)/P(all Ai containing
variants)
P(AijCk) = P(all Ai;Ck containing variants)/P(all Ck containing
variants)
P(CkjAi) = P(all Ai;Ck containing variants)/P(all Ai containing
variants)
P(BjjCk) = P(all Bj;Ck containing variants)/P(all Ck containing
variants)
P(CkjBj) = P(all Bj;Ck containing variants)/P(all Bj containing
variants)
P(AijBj;Ck) = P(Ai;Bj;Ck containing variants)/P(all Bj;Ck
containing variants)
P(BjjAi;Ck) = P(Ai;Bj;Ck containing variants)/P(all Ai;Ck
containing variants)
P(CkjAi;Bj) = P(Ai;Bj;Ck containing variants)/P(all Ai;Bj
containing variants),
where i is 1 or 2, j is 0, 1 or 2, and k is 0 or 1.
For example, the probability of B1 knowing the occurrence of
A1 was calculated as follows:
P(B1jA1) = P(all A1;B1 containing variants)/P(all A1 con-
taining variants).
In each model, the predicted probability of a speciﬁc variant
was calculated by multiplying the probability (conditional or
nonconditional) of exon choices at the three sites. The predicted
copy number of a given variant was obtained by multiplying the
total measured copy number of slo-1 transcripts by the predicted
probability of a speciﬁc variant.
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Fig. S1. CAEq-PCR method. (A) Schematic of the alternatively spliced region of slo-1 and primer and probe recognition sequences. (B) Qualitative analysis of
PCR products for each A/C primer pair. The template was a cDNA library generated by RT with random hexamers and a slo-1 gene-speciﬁc primer from total
adult worm RNA extracts. PCR products were digested with BsmI where indicated, yielding fragments of the expected size for slo-1 speciﬁc ampliﬁcation. (C)
The speciﬁcity of each A/C primer pair was assessed by real-time PCR analysis (SYBR green). Each panel depicts representative ampliﬁcation curves for the
indicated A/C primer pair. In each case, separate reactions were run with four plasmid templates carrying the indicated slo-1 splice variants (one match, three
mismatches). ΔRn, relative ﬂuorescence changes after baseline subtraction. (D) The speciﬁcity of each B probe was assessed by probe-hydrolysis (Taqman) qPCR
with matched A/C primers. Each panel depicts representative ampliﬁcation curves for the indicated probe. In each case, separate reactions were run with three
plasmid templates carrying the indicated slo-1 splice variants (one probe match, two probe mismatches). ΔRn, relative ﬂuorescence changes after baseline
subtraction.
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Fig. S2. Analysis of the titration effect in CAE-qPCR between A2;B1;C0 (target) and A2;B0;C0 (competitor). (A) Representative A2;B0;C0 and A2;B1;C0 am-
pliﬁcation curves are depicted for pure plasmid serial dilutions and worm lysate-derived cDNAs (biological sample). Copy numbers for pure plasmids were
30,000, 1,200, and 48 for A2;B0;C0; and 6,250, 250, and 10 for A2;B1;C0. (B) 250 copies of A2;B1;C0 were ampliﬁed in the presence of the indicated copy
numbers of the A2;B0;C0 competitor (both templates from plasmid). Reactions were performed in triplicate with the A2/B1/C0 primer and probe set. Rep-
resentative ampliﬁcation curves are depicted. (C) Indicated numbers of A2;B1;C0 copies were ampliﬁed in the absence or presence of 5,000 copies of A2;B0;C0
competitor (both templates from plasmids). Reactions were performed in triplicate with the A2/B1/C0 primer and probe set. Representative ampliﬁcation
curves are depicted. (D) A mix of A2;B0;C0 and A2;B1;C0 plasmid cDNAs was made to match the concentration measured in worm lysate-derived cDNAs. This
reconstructed sample was compared with worm lysate-derived cDNAs (real biological sample). Reactions were performed in triplicate with the A2/B1/C0 primer
and probe set. Representative ampliﬁcation curves are depicted. ΔRn, relative ﬂuorescence changes after baseline subtraction.
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Fig. S3. Measured distribution of the 12 slo-1 variants in wild type. Copy numbers of each slo-1 splice variant were measured by CAE-qPCR, and the fraction of
the total copy number is shown for each splice variant. Errors bars are 99% conﬁdence intervals of the means. ND, not detectable.
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Fig. S4. Systematic survey of conditional probability models. Models assuming zero, one, or two interactions among splicing decisions at sites A, B, and C were
created as described in SI Materials and Methods. Predicted values were calculated for wild type and compared with measured values. Models were clustered
according to the fraction of splice variants for which predictions were within the 99% conﬁdence interval of the mean measured values. Data were log
transformed, and the differences between predicted and empirical values were used to create a color scale reﬂecting the level of concordance/discrepancy
between them. In the model description, arrows indicate interactions, and semicolons separate independent splicing decisions.
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Fig. S5. Probability-based modeling for the pg52 mutant. Copy numbers of each slo-1 splice variant were measured by CAE-qPCR in pg52 adult worms and
their means plotted against the corresponding predicted values. (A and B) Predictions were calculated according to the indicated formulas. Error bars are 99%
conﬁdence intervals of the means (n = 5). The solid line shows the relationship expected for a perfect match between the two datasets. Probability values for
the independent splicing model (A) were: P(A1) = 0.349, P(A2) = 0.651, P(B0) = 0.449, P(B1) = 0.220, P(B2) = 0.331, P(C0) = 0.810, and P(C1) = 0.190. Probability
values for the interdependent splicing model (B) were: P(A1) = 0.349, P(A2) = 0.651, P(B0jA1) = 0.000, P(B1jA1) = 0.498, P(B2jA1) = 0.502, P(B0jA2) = 0.912,
P(B1jA2) = 0.028, P(B2jA2) = 0.060. P(C0jA1B0) = 0.000, P(C1jA1B0) = 0.000, P(C0jA1B1) = 0.118, P(C1jA1B1) = 0.882, P(C0jA1B2) = 0.785, P(C1jA1B2) = 0.215,
P(C0jA2B0) = 0.973, P(C1jA2B0) = 0.027, P(C0jA2B1) = 0.754, P(C1jA2B1) = 0.246, P(C0jA2B2) = 0.933, and P(C1jA2B2) = 0.067.

ht
tp
://
do
c.
re
ro
.c
h
Table S1. Oligonucleotide sequences
Name Sequence (5′ to 3′) Use
slo-1 A1 fwd GAGTCCTTCGTTTGCGAATATGTCA CAE-qPCR
slo-1 A2 fwd ATCCCACTCGTTCGTCGGAA CAE-qPCR
slo-1 C0 rev CGGAAGATGGCCTCTGTTGA CAE-qPCR
slo-1 C1 rev GTGTTGAGATGAGTATCACTCG CAE-qPCR
slo-1 B0 probe GGCCCGTGCAAGAGCCACCGA CAE-qPCR
slo-1 B1 probe CCCGTGATTATTCGGACTTTGAC CAE-qPCR
slo-1 B2 probe CGGCCCGTGAAAAAAATGCCAA CAE-qPCR
total slo-1 fwd TTGAGCAGCAATTCCAAGACATGAA Dye-based qPCR
total slo-1 rev GCGCGTAAATCTGCTCGAGATAG Dye-based qPCR
cdc-42 fwd CTGCTGGACAGGAAGATTACG Dye-based qPCR
cdc-42 rev CTCGGACATTCTCGAATGAAG Dye-based qPCR
pmp-3 fwd GTTCCCGTGTTCATCACTCAT Dye-based qPCR
pmp-3 rev ACACCGTCGAGAAGCTGTAGA Dye-based qPCR
slo-1A1 fwd GAGTCCTTCGTTTGCGAATATGTCA Dye-based qPCR at site A
slo-1A2 fwd ATCCCACTCGTTCGTCGGAA Dye-based qPCR at site A
slo-1 A rev GAAACGTCCTTAATATCGTCATGACACT Dye-based qPCR at site A
slo-1 B fwd GCTTCTTCTTCTGGCGATTGAGC Dye-based qPCR at site B
slo-1 B0 rev TGGCTCTTGCACGGGC Dye-based qPCR at site B
slo-1 B1 rev CGTCAAAGTCCGAATAATCACGGG Dye-based qPCR at site B
slo-1 B2 rev CGAATAATCTGAAATTTTGGCATTTTTTTCACG Dye-based qPCR at site B
slo-1 C fwd AGTGTCATGACGATATTAAGGACGTTTC Dye-based qPCR at site C
slo-1 C0 rev CGGAAGATGGCCTCTGTTGA Dye-based qPCR at site C
slo-1 C1 rev GTGTTGAGATGAGTATCACTCG Dye-based qPCR at site C
slo-1 exon 1 fwd CCACTAGTTTCTGGTGATGAC slo-1 sequencing
slo-1 exon 1 rev TTGAAAGCTGGCAACCTCAG slo-1 sequencing
slo-1 exon 2 fwd GCTCTCACTCTTCCAAATCC slo-1 sequencing
slo-1 exon 2 rev AGCTGCATCGCTAGAGAATC slo-1 sequencing
slo-1 exon 3 fwd ACCGAGTGAGTTTGATGTAGC slo-1 sequencing
slo-1 exon 5 rev CATATCAGCTGGGTTCTGAG slo-1 sequencing
slo-1 exon 6 fwd CTCAGAACCCAGCTGATATG slo-1 sequencing
slo-1 exon 6 rev GTCGGCCGCAAAGCGTCGTAC slo-1 sequencing
slo-1 exon 7 fwd GTAAAACTGTCCTGTGTACC slo-1 sequencing
slo-1 exon 7 rev AGTCGCATAACTCAGTCAG slo-1 sequencing
slo-1 exon 8 fwd GAGATCCATATCTCAGGCAG slo-1 sequencing
slo-1 exon 8 rev ATGATGTCCCATGTGCATGC slo-1 sequencing
slo-1 exon 9 fwd CGAAAGTAGGCCGTTTCAG slo-1 sequencing
slo-1 exon 9 rev CCTATCTTGGCATGGTTTG slo-1 sequencing
slo-1 exon 10 fwd ATTTCTGGCCCAAATTAGGC slo-1 sequencing
slo-1 exon 10 rev TGTTCGATTCACCTTGTCGA slo-1 sequencing
slo-1 exon 11 fwd TTGGACATGCTAGATCGAC slo-1 sequencing
slo-1 exon 11 rev GATTATGGTCGATATGGGTG slo-1 sequencing
slo-1 exon 12 fwd CCTAGTCAATATGGATGTCATACG slo-1 sequencing
slo-1 exon 13 rev AAACAGAGCGTCAAAGTCC slo-1 sequencing
slo-1 exon 14 fwd TATAGCGAATATGGGTGTC slo-1 sequencing
slo-1 exon 15 rev TTCAAAGGCGTCTAAGGGTGTG slo-1 sequencing
slo-1 exon 16 fwd GCTCACTTTTCAGCTTTCTAGC slo-1 sequencing
slo-1 exon 16 rev CAGAAGCTGAAAACTTGCTTG slo-1 sequencing
slo-1 exon 17 fwd GAGTTTTCGCAGTAAGACC slo-1 sequencing
slo-1 exon 17 rev CCATAACTTTGTTCAATCTCAACG slo-1 sequencing
slo-1 exon 18 fwd GGTTCCAAAATAGTGTTTCTTGACC slo-1 sequencing
slo-1 exon 18 rev TGTTCGAACCCACCAAGCTC slo-1 sequencing
slo-1 exon 19 fwd GTCGCAGTATTATTTCAAGC slo-1 sequencing
slo-1 exon 19 rev GTCGCGTAACTTTGTCAG slo-1 sequencing
slo-1 exon 20 fwd CGAAATAGGCCGATAAGC slo-1 sequencing
slo-1 exon 20 rev CGGTACACTGCAGCTTAAAACTGG slo-1 sequencing
slo-1 exon 21 fwd CCTAGCCAATATGAGTGTC slo-1 sequencing
slo-1 exon 22 rev ATTCAGGTCCACACGATACC slo-1 sequencing

ht
tp
://
do
c.
re
ro
.c
h
Table S3. Cross-reactivity factors for A/C exon combinations
Primer pair
AC combination in template
A1C0 A1C1 A2C0 A2C1
A1/C0 — ND ND ND
A1/C1 ND — ND 0.004
A2/C0 0.006 ND — ND
A2/C1 ND ND ND —
ND, not detected (<0.001).
Table S2. Cross-reactivity factors for B-type exons
Probe
B-type exon in template
B0 B1 B2
B0 — 0.031 0.025
B1 ND — ND
B2 ND ND —
ND, not detected (<0.001).
Table S4. CAE-qPCR standard curve values
Variant Threshold Slope Intercept R2 Calculated efﬁciency (%)
A1B0C0 0.005 −3.23 27.86 0.996 104
A1B0C1 0.006 −3.89 28.24 0.991 81
A2B0C0 0.028 −3.32 30.14 0.999 100
A2B0C1 0.029 −3.35 30.12 0.999 99
A1B1C0 0.034 −3.32 29.20 0.998 100
A1B1C1 0.016 −3.31 28.13 0.996 100
A2B1C0 0.009 −3.33 28.21 0.988 100
A2B1C1 0.011 −3.37 27.55 0.995 98
A1B2C0 0.034 −3.47 29.32 0.997 94
A1B2C1 0.031 −3.43 28.96 0.999 96
A2B2C0 0.039 −3.49 29.16 0.992 94
A2B2C1 0.019 −3.40 28.06 0.999 97
Table S5. Predicted vs. measured copy numbers of slo-1 variants in wild type
slo-1 variants
Predicted values according to model: A1B0C0 A1B0C1 A2B0C0 A2B0C1 A1B1C0 A1B1C1 A2B1C0 A2B1C1 A1B2C0 A1B2C1 A2B2C0 A2B2C1
A;B;C 1,666 625 1,964 737 1,363 511 1,606 603 683 256 805 302
A->B;C 0 0 3,097 1,162 3,903 1,465 192 72 709 266 186 70
A;B->C 1,976 21 2,330 26 605 1,958 714 2,309 241 302 284 356
A->C;B 633 2,215 2,095 51 517 1,811 1,713 42 259 907 858 21
B->A;C 0 0 3,165 1,188 3,862 1,449 200 75 674 253 186 70
C->B; A 1,962 2,056 2,313 2,424 590 128 696 151 245 124 288 146
C->A;B 611 2,204 2,125 54 499 1,802 1,738 44 250 903 871 22
A->B; A->C 0 0 4,157 102 1,193 4,175 258 6 217 758 250 6
A->B->C 0 0 4,213 46 1,267 4,100 62 202 433 543 114 143
A->C->B 989 4,396 3,273 102 297 273 985 6 123 264 408 6
B->A; B->C 0 0 4,306 47 1,254 4,057 65 210 411 516 114 143
B->A->C 0 0 4,249 104 1,180 4,130 269 7 206 721 250 6
B->C->A 961 46 3,345 1 294 4,166 1,024 101 117 643 408 16
C->A;C->B 954 4,374 3,321 106 287 272 999 7 119 263 414 6
C->A->B 0 0 4,219 106 1,151 4,154 262 7 209 755 254 6
C->B->A 0 0 4,276 4,480 1,223 265 63 14 418 211 115 58
A->B; AB->C 0 0 4,334 47 1,149 4,372 211 61 301 702 254 9
Measured values (mean) ND ND 4,249 46 1,071 4,296 207 60 280 655 249 9
99% CI lower bound ND ND 3,205 26 649 3,131 115 41 158 433 177 5.7
99% CI upper bound ND ND 5,292 67 1,492 5,461 299 79 402 877 321 12.4
Predicted values that are within the 99% conﬁdence interval (CI) of the measured values are in bold.
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Table S6. Predicted vs. measured copy numbers of slo-1 variants in pg52 mutant
slo-1 variants
Predicted values according to model: A1B0C0 A1B0C1 A2B0C0 A2B0C1 A1B1C0 A1B1C1 A2B1C0 A2B1C1 A1B2C0 A1B2C1 A2B2C0 A2B2C1
A;B;C 949 223 1,768 415 464 109 864 203 699 164 1,303 306
A->B;C 0 0 3,589 842 1,053 247 110 26 1,059 249 235 55
A;B->C 1,141 31 2,125 58 88 485 164 903 692 171 1,290 319
A->C;B 530 641 2,106 77 259 313 1,029 38 391 473 1,552 57
B->A;C 0 0 2,717 638 1,254 294 74 17 1,780 418 222 52
C->B; A 1,342 22 2,501 40 117 379 218 706 653 95 1,217 177
C->A;B 841 597 1,876 40 411 292 917 20 620 440 1,383 30
A->B; A->C 0 0 4,276 156 588 712 132 5 592 716 280 10
A->B->C 0 0 4,314 118 199 1,101 21 115 1,049 259 233 58
A->C->B 750 62 2,979 7 65 1,092 259 131 365 273 1,449 33
B->A; B->C 0 0 3,266 89 237 1,311 14 77 1,762 436 220 54
B->A->C 0 0 3,237 118 701 847 88 3 995 1,203 265 10
B->C->A 1,011 84 2,255 6 78 1,301 174 88 613 459 1,369 31
C->A;C->B 1,189 58 2,654 4 104 1,017 231 69 579 255 1,291 17
C->A->B 0 0 3,809 82 933 663 117 3 939 667 250 5
C->B->A 0 0 3,843 62 316 1,025 19 60 1,662 242 207 30
A->B; AB->C 0 0 3,575 39 349 1,326 86 25 505 1,180 228 8
Measured values (mean) ND ND 3,391 93 214 1,604 81 26 1,437 393 213 15
99% CI lower bound ND ND 2,221 64 163 944 34 11 445 185 158 5
99% CI upper bound ND ND 4,561 121 266 2,263 128 42 2,429 600 268 25
Predicted values that are within the 99% conﬁdence interval (CI) of the measured values are in bold.
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Table S7. Gene Ontology (GO) term analysis in the UAAAUC group
Gene WB ID
Gene
public
name
Sequence
name
(gene) GO ID (merged)
WBGene00000160 apb-1 Y71H2B.10 GO:0008565 j GO:0002119 j GO:0000003 j GO:0040007 j
GO:0030131 j GO:0006886 j GO:0009792 j GO:0005488 j
GO:0030117 j GO:0006898 j GO:0006461 j GO:0016192 j GO:0005515
WBGene00000254 bli-4 K04F10.4 GO:0009790 j GO:0010171 j GO:0002119 j GO:0004289 j GO:0040007 j
GO:0018996 j GO:0009792 j GO:0040002 j GO:0016808 j GO:0016021 j
GO:0040011 j GO:0006508 j GO:0005634
WBGene00000383 cdc-14 C17G10.4 GO:0040010 j GO:0030496 j GO:0003676 j GO:0006470 j GO:0004725 j
GO:0016791 j GO:0008138 j GO:0005819 j GO:0016311
WBGene00000397 cdh-5 F08B4.2 GO:0005509 j GO:0016020 j GO:0007156 j GO:0016021
WBGene00000415 ced-1 Y47H9C.4 GO:0005886 j GO:0005509 j GO:0005044 j GO:0043652 j
GO:0016021 j GO:0043654
WBGene00001340 etr-1 T01D1.2 GO:0010171 j GO:0003723 j GO:0002119 j GO:0005576 j GO:0009792 j
GO:0018991 j GO:0048477 j GO:0003676 j GO:0040011 j GO:0000166
WBGene00001518 gar-2 F47D12.1 GO:0004977 j GO:0016021 j GO:0004981 j GO:0016759 j GO:0006011 j
GO:0016020 j GO:0004989 j GO:0016907 j GO:0007186 j GO:0001584
WBGene00003153 mca-3 Y67D8C.10 GO:0040010 j GO:0006810 j GO:0016021 j GO:0006812 j GO:0008152 j
GO:0002119 j GO:0008340 j GO:0009792 j GO:0003824 j GO:0006897 j
GO:0016020 j GO:0051481 j GO:0015085 j GO:0040011 j GO:0006816 j
GO:0005388 j GO:0005886 j GO:0005509 j GO:0040017 j GO:0016820 j
GO:0005524 j GO:0015662 j GO:0045807
WBGene00003154 mcm-2 Y17G7B.5 GO:0008094 j GO:0003677 j GO:0017111 j GO:0000003 j GO:0009792 j
GO:0015979 j GO:0040035 j GO:0005634 j GO:0015995 j GO:0005524 j
GO:0000166 j GO:0016851 j GO:0006270
WBGene00003196 mel-11 C06C3.1 GO:0040010 j GO:0019684 j GO:0006118 j GO:0005737 j GO:0000003 j
GO:0009792 j GO:0045156 j GO:0005913 j GO:0030077
WBGene00003375 mlp-1 T04C9.4 GO:0008270
WBGene00003916 par-1 H39E23.1 GO:0045167 j GO:0009949 j GO:0000003 j GO:0009792 j GO:0040025 j
GO:0004674 j GO:0016020 j GO:0006468 j GO:0040035 j GO:0009880 j
GO:0004672 j GO:0004713 j GO:0030010 j GO:0005524 j GO:0005938
WBGene00003936 pat-12 T17H7.4 GO:0040010 j GO:0002119 j GO:0040007 j GO:0009792 j GO:0018996
WBGene00004161 pqn-80 Y111B2A.14 GO:0000003 j GO:0009792
WBGene00004373 rme-1 W06H8.1 GO:0005515 j GO:0005737 j GO:0003924 j GO:0005525 j GO:0012505 j
GO:0005509 j GO:0005622 j GO:0006898
WBGene00004389 rnp-6 Y47G6A.20 GO:0040010 j GO:0004499 j GO:0042309 j GO:0050825 j GO:0002119 j
GO:0000003 j GO:0009792 j GO:0050826 j GO:0018991 j GO:0050660 j
GO:0050661 j GO:0003676 j GO:0040035 j GO:0040011 j GO:0000166
WBGene00004830 slo-1 Y51A2D.19 GO:0005216 j GO:0016021 j GO:0008152 j GO:0042493 j GO:0046928 j
GO:0003824 j GO:0045202 j GO:0005249 j GO:0031430 j GO:0048149 j
GO:0043050 j GO:0050804 j GO:0016020 j GO:0030018 j GO:0005488 j
GO:0045214 j GO:0040011 j GO:0015269 j GO:0008076 j GO:0006811 j
GO:0006813
WBGene00004946 sop-3 Y71F9B.10 GO:0040010 j GO:0010171 j GO:0002119
WBGene00006490 tag-144 F36H1.2 GO:0040010 j GO:0010171 j GO:0016021 j GO:0005737 j
GO:0000003 j GO:0004812 j GO:0002009 j GO:0006412 j GO:0040035 j
GO:0006418 j GO:0005524 j GO:0000166
WBGene00006588 tnt-3 C14F5.3 GO:0006952 j GO:0071688 j GO:0043050 j GO:0019915
WBGene00006594 tom-1 M01A10.2 GO:0002119 j GO:0040007 j GO:0009792 j GO:0031201 j
GO:0016082 j GO:0040011
WBGene00006751 unc-11 C32E8.10 GO:0005543 j GO:0042309 j GO:0050825 j GO:0000003 j GO:0009792 j
GO:0050826 j GO:0030276 j GO:0005545 j GO:0030118 j GO:0040011 j
GO:0042734 j GO:0048488 j GO:0009791 j GO:0048268
WBGene00006759 unc-22 ZK617.1 GO:0005737 j GO:0004812 j GO:0004674 j GO:0006468 j GO:0006412 j
GO:0040011 j GO:0004672 j GO:0006418 j GO:0004713 j GO:0005524 j
GO:0031672 j GO:0000166
WBGene00006779 unc-43 K11E8.1 GO:0040018 j GO:0004674 j GO:0006468 j GO:0040011 j GO:0004672 j
GO:0040017 j GO:0004713 j GO:0005524
WBGene00006780 unc-44 B0350.2 GO:0040010 j GO:0010171 j GO:0007165 j GO:0004553 j GO:0005515 j
GO:0040018 j GO:0005975 j GO:0016328 j GO:0040011 j GO:0040017
WBGene00006791 unc-57 T04D1.3 GO:0005515 j GO:0005737 j GO:0004674 j GO:0006468 j GO:0040011 j
GO:0004672 j GO:0004713 j GO:0005524 j GO:0031594
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Table S7. Cont.
Gene WB ID
Gene
public
name
Sequence
name
(gene) GO ID (merged)
WBGene00006820 unc-89 C09D1.1 GO:0005021 j GO:0005089 j GO:0005975 j GO:0004674 j GO:0035023 j
GO:0006468 j GO:0040011 j GO:0004672 j GO:0004713 j GO:0005622 j
GO:0005524 j GO:0031672
WBGene00008570 F08A10.1 F08A10.1 GO:0016021 j GO:0016286 j GO:0016020 j GO:0005516 j GO:0005267 j
GO:0015269 j GO:0006813
WBGene00008694 F11C1.5 F11C1.5 GO:0004176 j GO:0005840 j GO:0017111 j GO:0019001 j GO:0004871 j
GO:0006412 j GO:0016887 j GO:0004252 j GO:0003735 j GO:0007186 j
GO:0005622 j GO:0005524 j GO:0000166 j GO:0006508
WBGene00010573 K04H4.2 K04H4.2 GO:0040010 j GO:0006030 j GO:0008061 j GO:0002119 j GO:0040007 j
GO:0005576 j GO:0040011
WBGene00012543 nkcc-1 Y37A1C.1 GO:0006810 j GO:0016021 j GO:0016020 j GO:0005215 j GO:0006811
WBGene00012814 Y43F8B.3 Y43F8B.3 GO:0004867
WBGene00013011 Y48E1B.14 Y48E1B.14 GO:0016021 j GO:0007154 j GO:0005515 j GO:0000003 j GO:0004871 j
GO:0007242 j GO:0035091
WBGene00013481 Y69H2.3 Y69H2.3 GO:0004857
WBGene00013805 Y116A8C.28 Y116A8C.28 GO:0004089 j GO:0015976 j GO:0008270
WBGene00015735 C13B9.4 C13B9.4 GO:0016021 j GO:0007189 j GO:0016020 j GO:0040011 j GO:0004948 j
GO:0006874 j GO:0045762 j GO:0004930
WBGene00016022 C23H3.9 C23H3.9 GO:0016021 j GO:0016787
WBGene00016115 C25H3.6 C25H3.6 GO:0003677 j GO:0003702 j GO:0010171 j GO:0003746 j GO:0005515 j
GO:0002119 j GO:0040007 j GO:0006355 j GO:0009792 j GO:0006354 j
GO:0006350 j GO:0030528 j GO:0040011 j GO:0005634 j GO:0016068
WBGene00016197 pxl-1 C28H8.6 GO:0040010 j GO:0002119 j GO:0040007 j GO:0009792 j
GO:0003676 j GO:0008270
WBGene00016561 C41D11.1 C41D11.1 GO:0000003
WBGene00017778 psf-1 F25B5.7 GO:0004872 j GO:0016021 j GO:0002119 j GO:0051260 j GO:0002009 j
GO:0016020 j GO:0003676 j GO:0007155 j GO:0000166
WBGene00018794 F54C4.3 F54C4.3 GO:0040010 j GO:0002119 j GO:0000003 j GO:0040007 j GO:0009792 j
GO:0002009 j GO:0003676 j GO:0040011 j GO:0008270 j GO:0005622 j
GO:0040015
WBGene00019636 gsto-3 K10F12.4 GO:0005737 j GO:0008152 j GO:0015035 j GO:0045454 j
GO:0004364 j GO:0009055
WBGene00021394 Y38C1AA.1 Y38C1AA.1 GO:0016021 j GO:0008152 j GO:0008415
WBGene00021562 nuo-5 Y45G12B.1 GO:0040010 j GO:0042773 j GO:0006118 j GO:0016651 j GO:0002119 j
GO:0040007 j GO:0009792 j GO:0051536 j GO:0016020 j GO:0003676 j
GO:0008137 j GO:0016491 j GO:0008270 j GO:0005622 j GO:0009055
WBGene00021784 cogc-4 Y51H7C.6 GO:0040010 j GO:0002119 j GO:0040007 j GO:0009792 j GO:0018991 j
GO:0002009 j GO:0040035 j GO:0040011 j GO:0035262 j GO:0030334
WBGene00022500 lﬁ-1 ZC8.4 GO:0007165 j GO:0016032 j GO:0043565 j GO:0046983 j GO:0005828 j
GO:0003700 j GO:0006355 j GO:0004871 j GO:0005634
WBGene00185002 K11H3.8 K11H3.8 GO:0005622 j GO:0008270
UAAAUC group: genes with at least two alternative splice sites, that each contains a UAAAUC element in an adjacent intron.
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